These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23990715)

  • 1. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
    He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
    Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anionic solid lipid nanoparticles supported on protamine/DNA complexes.
    Ye J; Wang A; Liu C; Chen Z; Zhang N
    Nanotechnology; 2008 Jul; 19(28):285708. PubMed ID: 21828742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.
    Suñé-Pou M; Prieto-Sánchez S; El Yousfi Y; Boyero-Corral S; Nardi-Ricart A; Nofrerias-Roig I; Pérez-Lozano P; García-Montoya E; Miñarro-Carmona M; Ticó JR; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Int J Nanomedicine; 2018; 13():3223-3233. PubMed ID: 29881274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.
    Delgado D; del Pozo-Rodríguez A; Solinís MÁ; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2011 Nov; 79(3):495-502. PubMed ID: 21726641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.
    Vighi E; Montanari M; Ruozi B; Tosi G; Magli A; Leo E
    Eur J Pharm Biopharm; 2010 Nov; 76(3):384-93. PubMed ID: 20691262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ternary complex of plasmid DNA with NLS-Mu-Mu protein and cationic niosome for biocompatible and efficient gene delivery: a comparative study with protamine and lipofectamine.
    Nematollahi MH; Torkzadeh-Mahanai M; Pardakhty A; Ebrahimi Meimand HA; Asadikaram G
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1781-1791. PubMed ID: 29081256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
    Vighi E; Ruozi B; Montanari M; Battini R; Leo E
    Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine sulfate-calcium carbonate-plasmid DNA ternary nanoparticles for efficient gene delivery.
    Wang CQ; Wu JL; Zhuo RX; Cheng SX
    Mol Biosyst; 2014 Mar; 10(3):672-8. PubMed ID: 24442276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency.
    de Jesus MB; Radaic A; Hinrichs WL; Ferreira CV; de Paula E; Hoekstra D; Zuhorn IS
    J Biomed Nanotechnol; 2014 Feb; 10(2):355-65. PubMed ID: 24738343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier.
    Vighi E; Montanari M; Ruozi B; Iannuccelli V; Leo E
    Drug Deliv; 2012 Jan; 19(1):1-10. PubMed ID: 22070724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine.
    Puras G; Martínez-Navarrete G; Mashal M; Zárate J; Agirre M; Ojeda E; Grijalvo S; Eritja R; Diaz-Tahoces A; Avilés-Trigueros M; Fernández E; Pedraz JL
    Mol Pharm; 2015 Oct; 12(10):3658-71. PubMed ID: 26334586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.
    Fàbregas A; Sánchez-Hernández N; Ticó JR; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Hernández-Munain C; Suñé C; Miñarro M
    Int J Pharm; 2014 Oct; 473(1-2):270-9. PubMed ID: 24999055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.
    Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E
    Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
    Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
    J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved formulation of cationic solid lipid nanoparticles displays cellular uptake and biological activity of nucleic acids.
    Fàbregas A; Prieto-Sánchez S; Suñé-Pou M; Boyero-Corral S; Ticó JR; García-Montoya E; Pérez-Lozano P; Miñarro M; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Int J Pharm; 2017 Jan; 516(1-2):39-44. PubMed ID: 27840160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ternary complex of plasmid DNA with protamine and γ-polyglutamic acid for biocompatible gene delivery system.
    Kanda K; Kodama Y; Kurosaki T; Imamura M; Nakagawa H; Muro T; Higuchi N; Nakamura T; Kitahara T; Honda M; Sasaki H
    Biol Pharm Bull; 2013; 36(11):1794-9. PubMed ID: 24189422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA.
    Erdem-Çakmak F; Özbaş-Turan S; Şalva E; Akbuğa J
    Cell Biol Int; 2014 Nov; 38(11):1260-70. PubMed ID: 24890139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quaternary complexes composed of plasmid DNA/protamine/fish sperm DNA/stearic acid grafted chitosan oligosaccharide micelles for gene delivery.
    Du YZ; Lu P; Yuan H; Zhou JP; Hu FQ
    Int J Biol Macromol; 2011 Jan; 48(1):153-9. PubMed ID: 21035503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.